Jefferies maintains Roivant Sciences at Buy; PT raised to $52
Jefferies maintains a Buy rating on Roivant Sciences and raises its price target to $52.00 per share from $42.00, per Benzinga/TradingView News.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.